NO912943D0 - Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser. - Google Patents

Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser.

Info

Publication number
NO912943D0
NO912943D0 NO912943A NO912943A NO912943D0 NO 912943 D0 NO912943 D0 NO 912943D0 NO 912943 A NO912943 A NO 912943A NO 912943 A NO912943 A NO 912943A NO 912943 D0 NO912943 D0 NO 912943D0
Authority
NO
Norway
Prior art keywords
pct
treatment
demylination
disorders
long
Prior art date
Application number
NO912943A
Other languages
English (en)
Norwegian (no)
Other versions
NO912943L (no
Inventor
Keith Coupland
Nigel Alan Langley
Original Assignee
Croda Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898927109A external-priority patent/GB8927109D0/en
Priority claimed from GB909016660A external-priority patent/GB9016660D0/en
Application filed by Croda Int Plc filed Critical Croda Int Plc
Publication of NO912943L publication Critical patent/NO912943L/no
Publication of NO912943D0 publication Critical patent/NO912943D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO912943A 1989-11-30 1991-07-29 Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser. NO912943D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898927109A GB8927109D0 (en) 1989-11-30 1989-11-30 Pharmaceutical compositions
GB909016660A GB9016660D0 (en) 1990-07-30 1990-07-30 Pharmaceutical compositions
PCT/GB1990/001870 WO1991007955A1 (en) 1989-11-30 1990-11-30 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders

Publications (2)

Publication Number Publication Date
NO912943L NO912943L (no) 1991-07-29
NO912943D0 true NO912943D0 (no) 1991-07-29

Family

ID=26296282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912943A NO912943D0 (no) 1989-11-30 1991-07-29 Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser.

Country Status (10)

Country Link
US (1) US5194448A (da)
EP (1) EP0455783B1 (da)
JP (1) JPH07500566A (da)
AT (1) ATE135208T1 (da)
DE (1) DE69025922T2 (da)
DK (1) DK0455783T3 (da)
ES (1) ES2087165T3 (da)
GR (1) GR3019315T3 (da)
NO (1) NO912943D0 (da)
WO (1) WO1991007955A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
GB9416846D0 (en) * 1994-08-19 1994-10-12 Croda Int Plc Lipid supplementation
GB9418420D0 (en) * 1994-09-13 1994-11-02 Mckeown Neil A Composition for the treatment of an energy imbalance in ruminents
IL119661A0 (en) * 1996-11-20 1997-02-18 Yehuda Shlomo Medical use of composition comprising fatty acids
DE19711777A1 (de) * 1997-03-21 1998-09-24 K D Pharma Gmbh Bestandteil eines Hautpflegemittels
US6652866B1 (en) * 1997-10-14 2003-11-25 David W. Hertha Method for treating diseases of fungal, yeast, and prion protein etiology
US6126986A (en) * 1999-02-23 2000-10-03 Westway Trading Corporation Process for formulating a liquid animal feed ingredient containing sugar and neutralized carboxylic acid
GB9927629D0 (en) * 1999-11-24 2000-01-19 Croda Int Plc Compounds
GB0112324D0 (en) * 2001-05-21 2001-07-11 Croda Int Plc Compounds
DE10148065A1 (de) * 2001-09-28 2003-04-17 Max Planck Gesellschaft (Ester)-Lysolecithine in Liposomen
US6949586B2 (en) * 2002-02-11 2005-09-27 Council Of Scientific Research Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
WO2007110358A2 (en) * 2006-03-24 2007-10-04 Metanomics Gmbh Means and method for predicting diabetes
US8269062B2 (en) 2006-11-21 2012-09-18 National Research Council Of Canada Lunaria annua, Cardamine graeca and Teesdalia nudicaulis FAE genes and their use in producing nervonic and eicosenoic acids in seed oils
DK2493296T3 (da) 2009-10-30 2019-04-15 Retrotope Inc Lindring af oxidative stresstilstande med pufa-derivater
WO2012148926A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating pufas
AU2012249921B2 (en) 2011-04-26 2017-06-08 Biojiva Llc Oxidative retinal diseases
CA2834342C (en) 2011-04-26 2021-08-31 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
JP6145087B2 (ja) 2011-04-26 2017-06-07 レトロトップ、 インコーポレイテッドＲｅｔｒｏｔｏｐｅ， Ｉｎｃ． Ｐｕｆａ酸化関与障害
EP2780316B1 (en) * 2011-11-13 2020-04-15 Blanchette Rockefeller Neurosciences Institute Esters of dcpla and methods of treatment using the same
EP3858843A1 (en) 2015-11-23 2021-08-04 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
CN105853996A (zh) * 2016-03-31 2016-08-17 山东健科生物技术有限公司 一种脑神经激活修复液
CN107441130A (zh) * 2017-08-04 2017-12-08 杨宇明 一种含蒜头果有效提取物的抗阿尔茨海默病的组合物及其应用
NO20181574A1 (en) * 2018-12-06 2020-06-08 Epax Norway As Very long chain fatty acids
WO2020242322A1 (en) * 2019-05-31 2020-12-03 Epax Norway As Very long chain fatty acids for treatment and alleviation of diseases
WO2021062383A1 (en) * 2019-09-27 2021-04-01 University Of Virginia Patent Foundation Compositions and methods for preventing and/or reducing weight gain and associated conditions
WO2021168311A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
CN111735888B (zh) * 2020-08-14 2020-11-20 宝枫生物科技（北京）有限公司 用于诊断元宝枫籽油中神经酸起效的生物标记物及其应用
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU558002B2 (en) * 1981-07-14 1987-01-15 Scotia Holdings Plc Enhancement of 1 series pg production using retinol or carotenoids and linolenic acid
US4505933A (en) * 1982-02-01 1985-03-19 Hoerrmann Wilhelm Fatty aldehydes in the treatment of Multiple Sclerosis
CH679119A5 (da) * 1988-05-13 1991-12-31 Sandoz Ag

Also Published As

Publication number Publication date
NO912943L (no) 1991-07-29
WO1991007955A1 (en) 1991-06-13
US5194448A (en) 1993-03-16
EP0455783B1 (en) 1996-03-13
ES2087165T3 (es) 1996-07-16
EP0455783A1 (en) 1991-11-13
DK0455783T3 (da) 1996-04-01
DE69025922T2 (de) 1996-10-02
JPH07500566A (ja) 1995-01-19
ATE135208T1 (de) 1996-03-15
DE69025922D1 (de) 1996-04-18
GR3019315T3 (en) 1996-06-30

Similar Documents

Publication Publication Date Title
NO912943L (no) Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser.
DK0539448T3 (da) Levnedsmiddelsammensætninger og farmaceutiske sammensætninger indeholdende kortkædede, monoumættede fedtsyrer og fremgangsmåde til anvendelse
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
IT1176916B (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
HK37694A (en) Fatty acids compositions
MX171177B (es) Composicion para desinfectar sustratos
ATE8790T1 (de) Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ATE245427T1 (de) Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost
ES2062239T3 (es) Diamidas de acidos pirimidin-4,6-dicarboxilicos, procedimiento para su preparacion, utilizacion de las mismas, asi como medicamentos a base de estos compuestos.
DE60008127D1 (de) Diät mit hohem lipidgehalt
PH25313A (en) Carboxylic acid derivatives, pharmaceutical compositions containing them
ES2030017T3 (es) Procedimiento para la preparacion de una composicion emulsion.
GB8704904D0 (en) Composition
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
DE3878812D1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
MX169500B (es) Producion de sabor
SE8800989D0 (sv) Dietary composition and process for preparing same
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
SE8800990D0 (sv) Skin-regenerating cosmetic compositon and process for preparing same
NO170011C (no) Analogifremgangsmaate til fremstilling av propanolaminderivater
NO894083L (no) Farmasoeytiske blandinger for behandling av adrenoleukodystrophy.
DE69326075D1 (de) Verwendung von Zusammensetzungen essentieller Fettsäuren
ATE121626T1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
DE69231583D1 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
BG49398A1 (en) Means for inrooting of the actinades